ZPHC

Cabergoline ZPHC — 0.25 mg × 50 tablets

Name: Cabergoline ZPHC — 0.25 mg × 50 tablets
Brand: ZPHC

0 customer reviews

Price on request

Cabergoline — prolactin-control research compound 50 film-coated tablets × 0.25 mg Main function: lowers serum prolactin by activating pituitary D₂ receptors, keeping levels in the low-normal range. When it’s used: Trenbolone / Nandrolone studies, hyper-prolactinaemia models, libido or erectile-function research. Typical research dosing: 0.25 mg twice weekly (bloodwork-guided ceiling ≈ 1 mg / week). Expected benefits: prevents gynecomastia, water retention, mood swings, low libido and “tren coug

● Out of stock

SKU: cabergoline-zphc-0-25-mg-50-tablets-default
Brand: ZPHC
Category: Post Cycle Therapy (PCT), Oral Steroids, Cabergoline

Cabergoline ZPHC is a dopamine agonist formulated for precise prolactin control, supplied as 50 film-coated tablets of 0.25 mg pharmaceutical-grade Cabergoline.

Its main function is lowering serum prolactin by activating pituitary D2 receptors, keeping levels in the low-normal range. It is most often used alongside Trenbolone or Nandrolone-based cycles, in hyperprolactinaemia management, and in libido or erectile-function support, preventing gynecomastia, water retention, mood swings, low libido and "tren cough" associated with elevated prolactin.

Key Benefits

Precisely controls serum prolactin via D2 receptor activation
Prevents gynecomastia and water retention linked to high prolactin
Supports healthy libido and erectile function
Reduces mood swings and "tren cough" symptoms
Manufactured to strict QC standards (≥ 99% API purity, HPLC-verified, GMP tablet press, tamper-evident packaging)